UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3004) 3004
Newsletter (140) 140
Newspaper Article (44) 44
Book Chapter (30) 30
Magazine Article (13) 13
Dissertation (11) 11
Conference Proceeding (9) 9
Publication (2) 2
Reference (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
dasatinib (2850) 2850
science & technology (2097) 2097
humans (2009) 2009
life sciences & biomedicine (1991) 1991
oncology (1069) 1069
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (828) 828
pyrimidines - therapeutic use (751) 751
chronic myeloid leukemia (723) 723
female (722) 722
hematology (700) 700
male (694) 694
protein kinase inhibitors - therapeutic use (679) 679
thiazoles - therapeutic use (628) 628
imatinib mesylate (617) 617
antineoplastic agents - therapeutic use (580) 580
middle aged (545) 545
pyrimidines - pharmacology (544) 544
nilotinib (533) 533
imatinib (526) 526
research (526) 526
cancer (524) 524
protein kinase inhibitors - pharmacology (512) 512
animals (490) 490
thiazoles - pharmacology (463) 463
adult (460) 460
benzamides (458) 458
hemic and lymphatic diseases (456) 456
aged (442) 442
leukemia (426) 426
tyrosine (415) 415
cell line, tumor (390) 390
treatment outcome (364) 364
care and treatment (361) 361
piperazines - therapeutic use (355) 355
protein-tyrosine kinases - antagonists & inhibitors (327) 327
mice (322) 322
pyrimidines - adverse effects (316) 316
drug therapy (298) 298
antineoplastic agents - pharmacology (296) 296
pyrimidines - administration & dosage (292) 292
mutation (286) 286
protein kinase inhibitors - adverse effects (272) 272
drug resistance, neoplasm (268) 268
kinases (265) 265
dasatinib - therapeutic use (258) 258
thiazoles - adverse effects (249) 249
analysis (248) 248
fusion proteins, bcr-abl - genetics (247) 247
leukemia, myelogenous, chronic, bcr-abl positive - genetics (246) 246
thiazoles - administration & dosage (244) 244
pharmacology & pharmacy (239) 239
dasatinib - pharmacology (233) 233
protein kinase inhibitors - administration & dosage (226) 226
health aspects (207) 207
antineoplastic agents - adverse effects (203) 203
src-family kinases - antagonists & inhibitors (201) 201
aged, 80 and over (197) 197
abridged index medicus (196) 196
src-family kinases - metabolism (193) 193
tyrosine kinase inhibitors (193) 193
dosage and administration (189) 189
leukemia, myelogenous, chronic, bcr-abl positive - pathology (179) 179
fusion proteins, bcr-abl - antagonists & inhibitors (174) 174
cell proliferation - drug effects (173) 173
apoptosis - drug effects (171) 171
cell biology (169) 169
hematology, oncology and palliative medicine (168) 168
genetic aspects (167) 167
philadelphia chromosome (167) 167
phosphorylation (166) 166
protein-tyrosine kinase (166) 166
young adult (165) 165
piperazines - pharmacology (163) 163
chemotherapy (159) 159
medicine & public health (159) 159
tyrosine kinase inhibitor (159) 159
physical fitness (157) 157
apoptosis (156) 156
antineoplastic combined chemotherapy protocols - therapeutic use (155) 155
antineoplastic agents - administration & dosage (150) 150
oncology, experimental (150) 150
biochemistry & molecular biology (148) 148
antineoplastic agents (147) 147
signal transduction - drug effects (147) 147
patients (145) 145
proteins (143) 143
dasatinib - administration & dosage (142) 142
phenols (141) 141
tumors (134) 134
adolescent (132) 132
cml (130) 130
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (129) 129
prognosis (128) 128
antimitotic agents (125) 125
drug resistance (125) 125
stem cells (125) 125
bcr-abl (123) 123
signal transduction (123) 123
dose-response relationship, drug (120) 120
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3102) 3102
Japanese (61) 61
Chinese (39) 39
Polish (24) 24
Russian (20) 20
French (17) 17
Spanish (14) 14
German (12) 12
Czech (10) 10
Korean (8) 8
Italian (7) 7
Portuguese (7) 7
Turkish (5) 5
Danish (2) 2
Hebrew (2) 2
Finnish (1) 1
Hungarian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 5915 - 5915
Abstract Introduction Survival outcomes for patients with lymphoid, myeloid and plasma cell malignancies, have improved with the use of oral small molecule... 
Journal Article
European journal of clinical pharmacology, ISSN 1432-1041, 10/2015, Volume 72, Issue 2, pp. 185 - 193
Dasatinib is a novel, oral, multi-targeted kinase inhibitor of breakpoint cluster region-abelson (BCR-ABL) and Src family kinases. The study investigated... 
Dasatinib | Pharmacodynamics | Biomedicine | Half maximal inhibitory concentration | Phamacokinetics | Pharmacology/Toxicology | Molecular response | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Leukocytes, Mononuclear - metabolism | Antigens, CD34 - metabolism | Oncogene Protein v-crk - antagonists & inhibitors | Humans | Middle Aged | Oncogene Protein v-crk - metabolism | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Dasatinib - pharmacokinetics | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Phosphorylation - drug effects | Protein Kinase Inhibitors - pharmacokinetics | Leukocytes, Mononuclear - drug effects | Dasatinib - therapeutic use | Treatment Outcome | Dasatinib - pharmacology | Fusion Proteins, bcr-abl - genetics | Protein Kinase Inhibitors - therapeutic use | Fusion Proteins, bcr-abl - antagonists & inhibitors | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism | Aged | Dasatinib - adverse effects | Protein Kinase Inhibitors - pharmacology | Phosphotransferases | Analysis | Chronic myeloid leukemia | Pharmacology | Kinetics | Drug therapy | Leukemia | Chronic illnesses | Index Medicus
Journal Article
Biosensors & bioelectronics, ISSN 0956-5663, 12/2016, Volume 86, pp. 879 - 884
Journal Article
Annals of hematology, ISSN 1432-0584, 10/2017, Volume 97, Issue 1, pp. 95 - 100
Journal Article
Investigational new drugs, ISSN 1573-0646, 10/2017, Volume 36, Issue 3, pp. 416 - 423
Journal Article
Journal Article
Drugs (New York, N.Y.), ISSN 0012-6667, 01/2017, Volume 77, Issue 1, pp. 85 - 96
Journal Article
International journal of hematology, ISSN 0925-5710, 3/2018, Volume 107, Issue 3, pp. 373 - 377
Journal Article
Journal of controlled release, ISSN 0168-3659, 07/2017, Volume 258, pp. 43 - 55
Two novel prodrug polymers POEG-b-PSSDas (redox-sensitive) and POEG-b-PCCDas (redox-insensitive), which consist of poly(oligo(ethylene glycol) methacrylate)... 
Prodrug micelles | Dasatinib | Redox responsive | Co-delivery | Doxorubicin | Pharmacology & Pharmacy | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Prodrugs - administration & dosage | Doxorubicin - therapeutic use | Humans | Dasatinib - pharmacokinetics | Delayed-Action Preparations - chemistry | Polyethylene Glycols - chemistry | Drug Delivery Systems | Micelles | Female | Antibiotics, Antineoplastic - pharmacokinetics | Doxorubicin - administration & dosage | Protein Kinase Inhibitors - pharmacokinetics | Cell Survival - drug effects | Oxidation-Reduction | Dasatinib - therapeutic use | Doxorubicin - pharmacokinetics | Neoplasms - drug therapy | Antibiotics, Antineoplastic - administration & dosage | Protein Kinase Inhibitors - administration & dosage | Animals | Dasatinib - administration & dosage | Antibiotics, Antineoplastic - therapeutic use | Prodrugs - pharmacokinetics | Protein Kinase Inhibitors - therapeutic use | Cell Line, Tumor | Mice, Inbred BALB C | Prodrugs - therapeutic use | Neoplasms - pathology | Ethylene glycol | Anthracyclines | Chemotherapy | Polymers | Analysis | Cancer | Tyrosine | Medical colleges | Pharmacogenetics | Pharmacy | Physiological aspects | Drugstores | Index Medicus | co-delivery | dasatinib | doxorubicin | prodrug micelles | redox responsive
Journal Article